APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tuberculosis Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tuberculosis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025194 pages

Choose your research edition.

Industry ResearchTuberculosis Vaccine Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculosis Vaccine Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Tuberculosis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculosis Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculosis Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Tuberculosis Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tuberculosis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tuberculosis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tuberculosis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tuberculosis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tuberculosis Vaccine include AJ Vaccines, Ataulpho de Paiva, BioFarma, Biomed Lublin, GreenSignal Bio Pharma, IVAC, Japan BCG Lab, Microgen and Queen Saovabha Mem. Inst, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tuberculosis Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tuberculosis Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tuberculosis Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tuberculosis Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Tuberculosis Vaccine Segment by Company

AJ Vaccines

Ataulpho de Paiva

BioFarma

Biomed Lublin

GreenSignal Bio Pharma

IVAC

Japan BCG Lab

Microgen

Queen Saovabha Mem. Inst

Serum Institute of India

Taj Pharmaceuticals

Merck

China National Biotec

Tuberculosis Vaccine Segment by Type

Immune Vaccine

Therapy Vaccine

Tuberculosis Vaccine Segment by Application

Self-Procurement

UNICEF

Other

Tuberculosis Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tuberculosis Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tuberculosis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tuberculosis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tuberculosis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tuberculosis Vaccine Industry Trends Table 2. Tuberculosis Vaccine Industry Drivers Table 3. Tuberculosis Vaccine Industry Opportunities and Challenges Table 4. Tuberculosis Vaccine Industry Restraints Table 5. Global Tuberculosis Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tuberculosis Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tuberculosis Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Tuberculosis Vaccine Sales Market Share by Manufacturers Table 9. Global Tuberculosis Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Tuberculosis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tuberculosis Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tuberculosis Vaccine Manufacturers, Product Type & Application Table 13. Global Tuberculosis Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tuberculosis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Immune Vaccine Table 17. Major Manufacturers of Therapy Vaccine Table 18. Global Tuberculosis Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Tuberculosis Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Tuberculosis Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Tuberculosis Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Tuberculosis Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Tuberculosis Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Tuberculosis Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Tuberculosis Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Tuberculosis Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Tuberculosis Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Self-Procurement Table 29. Major Manufacturers of UNICEF Table 30. Major Manufacturers of Other Table 31. Global Tuberculosis Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Tuberculosis Vaccine Sales by Application (2021-2026) & (K Units) Table 33. Global Tuberculosis Vaccine Sales by Application (2027-2032) & (K Units) Table 34. Global Tuberculosis Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Tuberculosis Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Tuberculosis Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Tuberculosis Vaccine Revenue by Application (2021-2026) & (K Units) Table 38. Global Tuberculosis Vaccine Revenue by Application (2027-2032) & (K Units) Table 39. Global Tuberculosis Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Tuberculosis Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Tuberculosis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Tuberculosis Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Tuberculosis Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Tuberculosis Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Tuberculosis Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Tuberculosis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Tuberculosis Vaccine Sales by Country (2021-2026) & (K Units) Table 48. North America Tuberculosis Vaccine Sales by Country (2027-2032) & (K Units) Table 49. Europe Tuberculosis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Tuberculosis Vaccine Sales by Country (2021-2026) & (K Units) Table 51. Europe Tuberculosis Vaccine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Tuberculosis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Tuberculosis Vaccine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Tuberculosis Vaccine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Tuberculosis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Tuberculosis Vaccine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Tuberculosis Vaccine Sales by Country (2027-2032) & (K Units) Table 58. Global Tuberculosis Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Tuberculosis Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Tuberculosis Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Tuberculosis Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Tuberculosis Vaccine Revenue Market Share by Region (2027-2032) Table 63. AJ Vaccines Company Information Table 64. AJ Vaccines Business Overview Table 65. AJ Vaccines Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. AJ Vaccines Tuberculosis Vaccine Product Portfolio Table 67. AJ Vaccines Recent Development Table 68. Ataulpho de Paiva Company Information Table 69. Ataulpho de Paiva Business Overview Table 70. Ataulpho de Paiva Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Ataulpho de Paiva Tuberculosis Vaccine Product Portfolio Table 72. Ataulpho de Paiva Recent Development Table 73. BioFarma Company Information Table 74. BioFarma Business Overview Table 75. BioFarma Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. BioFarma Tuberculosis Vaccine Product Portfolio Table 77. BioFarma Recent Development Table 78. Biomed Lublin Company Information Table 79. Biomed Lublin Business Overview Table 80. Biomed Lublin Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Biomed Lublin Tuberculosis Vaccine Product Portfolio Table 82. Biomed Lublin Recent Development Table 83. GreenSignal Bio Pharma Company Information Table 84. GreenSignal Bio Pharma Business Overview Table 85. GreenSignal Bio Pharma Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. GreenSignal Bio Pharma Tuberculosis Vaccine Product Portfolio Table 87. GreenSignal Bio Pharma Recent Development Table 88. IVAC Company Information Table 89. IVAC Business Overview Table 90. IVAC Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. IVAC Tuberculosis Vaccine Product Portfolio Table 92. IVAC Recent Development Table 93. Japan BCG Lab Company Information Table 94. Japan BCG Lab Business Overview Table 95. Japan BCG Lab Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Japan BCG Lab Tuberculosis Vaccine Product Portfolio Table 97. Japan BCG Lab Recent Development Table 98. Microgen Company Information Table 99. Microgen Business Overview Table 100. Microgen Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Microgen Tuberculosis Vaccine Product Portfolio Table 102. Microgen Recent Development Table 103. Queen Saovabha Mem. Inst Company Information Table 104. Queen Saovabha Mem. Inst Business Overview Table 105. Queen Saovabha Mem. Inst Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Queen Saovabha Mem. Inst Tuberculosis Vaccine Product Portfolio Table 107. Queen Saovabha Mem. Inst Recent Development Table 108. Serum Institute of India Company Information Table 109. Serum Institute of India Business Overview Table 110. Serum Institute of India Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Serum Institute of India Tuberculosis Vaccine Product Portfolio Table 112. Serum Institute of India Recent Development Table 113. Taj Pharmaceuticals Company Information Table 114. Taj Pharmaceuticals Business Overview Table 115. Taj Pharmaceuticals Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Taj Pharmaceuticals Tuberculosis Vaccine Product Portfolio Table 117. Taj Pharmaceuticals Recent Development Table 118. Merck Company Information Table 119. Merck Business Overview Table 120. Merck Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Merck Tuberculosis Vaccine Product Portfolio Table 122. Merck Recent Development Table 123. China National Biotec Company Information Table 124. China National Biotec Business Overview Table 125. China National Biotec Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. China National Biotec Tuberculosis Vaccine Product Portfolio Table 127. China National Biotec Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Tuberculosis Vaccine Distributors List Table 131. Tuberculosis Vaccine Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Tuberculosis Vaccine Product Image Figure 2. Global Tuberculosis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tuberculosis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Tuberculosis Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Tuberculosis Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Tuberculosis Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Immune Vaccine Image Figure 9. Therapy Vaccine Image Figure 10. Global Tuberculosis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Tuberculosis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Tuberculosis Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Tuberculosis Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Tuberculosis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Tuberculosis Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Self-Procurement Image Figure 17. UNICEF Image Figure 18. Other Image Figure 19. Global Tuberculosis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Tuberculosis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Tuberculosis Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Tuberculosis Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Tuberculosis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Tuberculosis Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Tuberculosis Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Tuberculosis Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Tuberculosis Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Tuberculosis Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Tuberculosis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Tuberculosis Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Tuberculosis Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Tuberculosis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Tuberculosis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Tuberculosis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Tuberculosis Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Tuberculosis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Tuberculosis Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Tuberculosis Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Immune Vaccine
  • Therapy Vaccine
Applications
  • Self-Procurement
  • UNICEF
  • Other
Companies covered
  • AJ Vaccines
  • Ataulpho de Paiva
  • BioFarma
  • Biomed Lublin
  • GreenSignal Bio Pharma
  • IVAC
  • Japan BCG Lab
  • Microgen
  • Queen Saovabha Mem. Inst
  • Serum Institute of India
  • Taj Pharmaceuticals
  • Merck
  • China National Biotec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tuberculosis Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tuberculosis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tuberculosis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tuberculosis Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tuberculosis Vaccine Market Dynamics
  1. 2.1 Tuberculosis Vaccine Industry Trends
  2. 2.2 Tuberculosis Vaccine Industry Drivers
  3. 2.3 Tuberculosis Vaccine Industry Opportunities and Challenges
  4. 2.4 Tuberculosis Vaccine Industry Restraints
3 Tuberculosis Vaccine Market by Manufacturers
  1. 3.1 Global Tuberculosis Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tuberculosis Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tuberculosis Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tuberculosis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tuberculosis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tuberculosis Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Tuberculosis Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tuberculosis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tuberculosis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tuberculosis Vaccine Tier 1, Tier 2, and Tier 3
4 Tuberculosis Vaccine Market by Type
  1. 4.1 Tuberculosis Vaccine Type Introduction
  2. 4.1.1 Immune Vaccine
  3. 4.1.2 Therapy Vaccine
  4. 4.2 Global Tuberculosis Vaccine Sales by Type
  5. 4.2.1 Global Tuberculosis Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tuberculosis Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Tuberculosis Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Tuberculosis Vaccine Revenue by Type
  9. 4.3.1 Global Tuberculosis Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tuberculosis Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Tuberculosis Vaccine Revenue Market Share by Type (2021-2032)
5 Tuberculosis Vaccine Market by Application
  1. 5.1 Tuberculosis Vaccine Application Introduction
  2. 5.1.1 Self-Procurement
  3. 5.1.2 UNICEF
  4. 5.1.3 Other
  5. 5.2 Global Tuberculosis Vaccine Sales by Application
  6. 5.2.1 Global Tuberculosis Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tuberculosis Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Tuberculosis Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Tuberculosis Vaccine Revenue by Application
  10. 5.3.1 Global Tuberculosis Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Tuberculosis Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Tuberculosis Vaccine Revenue Market Share by Application (2021-2032)
6 Global Tuberculosis Vaccine Sales by Region
  1. 6.1 Global Tuberculosis Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tuberculosis Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Tuberculosis Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Tuberculosis Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tuberculosis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tuberculosis Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tuberculosis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tuberculosis Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tuberculosis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tuberculosis Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tuberculosis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tuberculosis Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tuberculosis Vaccine Revenue by Region
  1. 7.1 Global Tuberculosis Vaccine Revenue by Region
  2. 7.1.1 Global Tuberculosis Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tuberculosis Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Tuberculosis Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Tuberculosis Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tuberculosis Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Tuberculosis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tuberculosis Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Tuberculosis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tuberculosis Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tuberculosis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tuberculosis Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tuberculosis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AJ Vaccines
  2. 8.1.1 AJ Vaccines Company Information
  3. 8.1.2 AJ Vaccines Business Overview
  4. 8.1.3 AJ Vaccines Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AJ Vaccines Tuberculosis Vaccine Product Portfolio
  6. 8.1.5 AJ Vaccines Recent Developments
  7. 8.2 Ataulpho de Paiva
  8. 8.2.1 Ataulpho de Paiva Company Information
  9. 8.2.2 Ataulpho de Paiva Business Overview
  10. 8.2.3 Ataulpho de Paiva Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ataulpho de Paiva Tuberculosis Vaccine Product Portfolio
  12. 8.2.5 Ataulpho de Paiva Recent Developments
  13. 8.3 BioFarma
  14. 8.3.1 BioFarma Company Information
  15. 8.3.2 BioFarma Business Overview
  16. 8.3.3 BioFarma Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioFarma Tuberculosis Vaccine Product Portfolio
  18. 8.3.5 BioFarma Recent Developments
  19. 8.4 Biomed Lublin
  20. 8.4.1 Biomed Lublin Company Information
  21. 8.4.2 Biomed Lublin Business Overview
  22. 8.4.3 Biomed Lublin Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biomed Lublin Tuberculosis Vaccine Product Portfolio
  24. 8.4.5 Biomed Lublin Recent Developments
  25. 8.5 GreenSignal Bio Pharma
  26. 8.5.1 GreenSignal Bio Pharma Company Information
  27. 8.5.2 GreenSignal Bio Pharma Business Overview
  28. 8.5.3 GreenSignal Bio Pharma Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GreenSignal Bio Pharma Tuberculosis Vaccine Product Portfolio
  30. 8.5.5 GreenSignal Bio Pharma Recent Developments
  31. 8.6 IVAC
  32. 8.6.1 IVAC Company Information
  33. 8.6.2 IVAC Business Overview
  34. 8.6.3 IVAC Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 IVAC Tuberculosis Vaccine Product Portfolio
  36. 8.6.5 IVAC Recent Developments
  37. 8.7 Japan BCG Lab
  38. 8.7.1 Japan BCG Lab Company Information
  39. 8.7.2 Japan BCG Lab Business Overview
  40. 8.7.3 Japan BCG Lab Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Japan BCG Lab Tuberculosis Vaccine Product Portfolio
  42. 8.7.5 Japan BCG Lab Recent Developments
  43. 8.8 Microgen
  44. 8.8.1 Microgen Company Information
  45. 8.8.2 Microgen Business Overview
  46. 8.8.3 Microgen Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Microgen Tuberculosis Vaccine Product Portfolio
  48. 8.8.5 Microgen Recent Developments
  49. 8.9 Queen Saovabha Mem. Inst
  50. 8.9.1 Queen Saovabha Mem. Inst Company Information
  51. 8.9.2 Queen Saovabha Mem. Inst Business Overview
  52. 8.9.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Product Portfolio
  54. 8.9.5 Queen Saovabha Mem. Inst Recent Developments
  55. 8.10 Serum Institute of India
  56. 8.10.1 Serum Institute of India Company Information
  57. 8.10.2 Serum Institute of India Business Overview
  58. 8.10.3 Serum Institute of India Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Serum Institute of India Tuberculosis Vaccine Product Portfolio
  60. 8.10.5 Serum Institute of India Recent Developments
  61. 8.11 Taj Pharmaceuticals
  62. 8.11.1 Taj Pharmaceuticals Company Information
  63. 8.11.2 Taj Pharmaceuticals Business Overview
  64. 8.11.3 Taj Pharmaceuticals Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Taj Pharmaceuticals Tuberculosis Vaccine Product Portfolio
  66. 8.11.5 Taj Pharmaceuticals Recent Developments
  67. 8.12 Merck
  68. 8.12.1 Merck Company Information
  69. 8.12.2 Merck Business Overview
  70. 8.12.3 Merck Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Tuberculosis Vaccine Product Portfolio
  72. 8.12.5 Merck Recent Developments
  73. 8.13 China National Biotec
  74. 8.13.1 China National Biotec Company Information
  75. 8.13.2 China National Biotec Business Overview
  76. 8.13.3 China National Biotec Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 China National Biotec Tuberculosis Vaccine Product Portfolio
  78. 8.13.5 China National Biotec Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tuberculosis Vaccine Value Chain Analysis
  2. 9.1.1 Tuberculosis Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tuberculosis Vaccine Production Mode & Process
  6. 9.2 Tuberculosis Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tuberculosis Vaccine Distributors
  9. 9.2.3 Tuberculosis Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst